Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accumulation and erosion of Mars' south polar layered deposits.
Seu R, Phillips RJ, Alberti G, Biccari D, Bonaventura F, Bortone M, Calabrese D, Campbell BA, Cartacci M, Carter LM, Catallo C, Croce A, Croci R, Cutigni M, Di Placido A, Dinardo S, Federico C, Flamini E, Fois F, Frigeri A, Fuga O, Giacomoni E, Gim Y, Guelfi M, Holt JW, Kofman W, Leuschen CJ, Marinangeli L, Marras P, Masdea A, Mattei S, Mecozzi R, Milkovich SM, Morlupi A, Mouginot J, Orosei R, Papa C, Paternò T, Persi del Marmo P, Pettinelli E, Pica G, Picardi G, Plaut JJ, Provenziani M, Putzig NE, Russo F, Safaeinili A, Salzillo G, Santovito MR, Smrekar SE, Tattarletti B, Vicari D. Seu R, et al. Among authors: pica g. Science. 2007 Sep 21;317(5845):1715-8. doi: 10.1126/science.1144120. Science. 2007. PMID: 17885128
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
Camus V, Thieblemont C, Gaulard P, Cheminant M, Casasnovas RO, Ysebaert L, Damaj GL, Guidez S, Pica GM, Kim WS, Lim ST, Andre M, Gutiérrez N, Penarrubia MJ, Staber PB, Trotman J, Hüttmann A, Stefoni V, Tucci A, Fogarty P, Farhat H, Abraham J, Abarah W, Belmecheri F, Ribrag V, Delfau-Larue MH, Cottereau AS, Itti E, Li J, Delarue R, de Leval L, Morschhauser F, Bachy E. Camus V, et al. Among authors: pica gm. J Clin Oncol. 2024 Feb 16:JCO2301687. doi: 10.1200/JCO.23.01687. Online ahead of print. J Clin Oncol. 2024. PMID: 38364196
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Ghesquières H, Cherblanc F, Belot A, Micon S, Bouabdallah KK, Esnault C, Fornecker LM, Thokagevistk K, Bonjour M, Bijou F, Haioun C, Morineau N, Ysebaert L, Damaj G, Tessoulin B, Guidez S, Morschhauser F, Thiéblemont C, Chauchet A, Gressin R, Jardin F, Fruchart C, Labouré G, Fouillet L, Lionne-Huyghe P, Bonnet A, Lebras L, Amorim S, Leyronnas C, Olivier G, Guieze R, Houot R, Launay V, Drénou B, Fitoussi O, Detourmignies L, Abraham J, Soussain C, Lachenal F, Pica GM, Fogarty P, Cony-Makhoul P, Bernier A, Le Guyader-Peyrou S, Monnereau A, Boissard F, Rossi C, Camus V. Ghesquières H, et al. Among authors: pica gm. Blood Adv. 2024 Jan 23;8(2):296-308. doi: 10.1182/bloodadvances.2023010798. Blood Adv. 2024. PMID: 37874913 Free PMC article.
Enhancing charge extraction in inverted perovskite solar cells contacts via ultrathin graphene:fullerene composite interlayers.
Zanetta A, Bulfaro I, Faini F, Manzi M, Pica G, De Bastiani M, Bellani S, Zappia MI, Bianca G, Gabatel L, Panda JK, Del Rio Castillo AE, Prato M, Lauciello S, Bonaccorso F, Grancini G. Zanetta A, et al. Among authors: pica g. J Mater Chem A Mater. 2022 Nov 30;11(24):12866-12875. doi: 10.1039/d2ta07512a. eCollection 2023 Jun 20. J Mater Chem A Mater. 2022. PMID: 37346737 Free PMC article.
A fluorescent sensor to detect lead leakage from perovskite solar cells.
Pancini L, Montecucco R, Larini V, Benassi A, Mirani D, Pica G, De Bastiani M, Doria F, Grancini G. Pancini L, et al. Among authors: pica g. Mater Adv. 2023 May 18;4(11):2410-2417. doi: 10.1039/d3ma00068k. eCollection 2023 Jun 6. Mater Adv. 2023. PMID: 37287527 Free PMC article.
Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study.
Talbot A, Bobin A, Tabone L, Lambert J, Boccaccio C, Deal C, Petillon MO, Allangba O, Agape P, Arnautou P, Belkhir R, Cailleres S, Chaoui D, Chrétien ML, Decaux O, Schulmann S, Frenzel L, Gastaud L, Huart A, Hulin C, Karlin L, Laribi K, Le Calloch R, Lenain P, Macro M, Manier S, Montes L, Moreau S, Moreau P, Morel V, Norwood J, Piocelle FO, Perrot A, Pica GM, Rey P, Schmitt A, Stoppa AM, Tiab M, Touzeau C, Vidal V, Vignon M, Vincent L, Van De Wyngaert Z, Zarnitsky C, Kerbouche N, Paka P, Leleu X, Arnulf B, Avet-Loiseau H, Du Myélome IIF. Talbot A, et al. Among authors: pica gm. Haematologica. 2023 Oct 1;108(10):2774-2782. doi: 10.3324/haematol.2022.281772. Haematologica. 2023. PMID: 37078253 Free PMC article.
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study.
Cartron G, Bachy E, Tilly H, Daguindau N, Pica GM, Bijou F, Mounier C, Clavert A, Damaj GL, Slama B, Casasnovas O, Houot R, Bouabdallah K, Sibon D, Fitoussi O, Morineau N, Herbaux C, Gastinne T, Fornecker LM, Haioun C, Launay V, Araujo C, Benbrahim O, Sanhes L, Gressin R, Gonzalez H, Morschhauser F, Ternant D, Xerri L, Tarte K, Pranger D. Cartron G, et al. Among authors: pica gm. J Clin Oncol. 2023 Jul 1;41(19):3523-3533. doi: 10.1200/JCO.22.02327. Epub 2023 Apr 18. J Clin Oncol. 2023. PMID: 37071836 Free article. Clinical Trial.
92 results